IRCT20210519051345N42招募中Unknown
Investigating in vivo bioequivalence of Azithromycin 200 mg/5 ml suspension compared to innovator product Zithromax®
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
尚未招募
Unknown
Comparative bioequivalence study of the Azithromycin 500 mg, tablet manufactured by Nikasa Pharmed CompanyBioequivalence study in healthy volunteers.IRCT20130313012810N15ikasa Pharmed Company24
尚未招募
不适用
Bioequivalence study of Azithromycin 500 mg tabletIn the present study, no diseases will be examined and products will be administered by healthy volunteers..IRCT20210519051345N4Tabriz University of Medical Sciences24
尚未招募
不适用
Investigating the in vivo bioequivalence of Azithromycin 250 mg capsuleIRCT20210519051345N13Tabriz University of Medical Sciences24
尚未招募
Unknown
In-vivo Bioequivalence Study of Azithromycin 500 mg Capsules of The Test Drug (ZITHROSAD 500 mg Cap., Sajjad Darou, Iran)IRCT20200105046010N107Sajad darou shargh24
招募中
不适用
In-vivo Bioequivalence study of Azithromycin capsules 250 mg with brand drugs (ZITHROMAX® 250 mg Pfizer, Ireland)IRCT20200105046010N37Kharazmi Pharmaceutical Co24